Dyadic International: Funding, Investors & Team (Oct 2026)
Dyadic International, Inc. is a global biotechnology company based in Jupiter, Florida, with a research facility in the Netherlands. Using its unique technologies, Dyadic conducts research and development in order to discover, develop, manufacture, and sell enzymes and other proteins for various industries. The company's integrated technology platform, based on its patented C1 fungus, allows for the cost-effective production of enzymes and proteins for different market uses. Dyadic also explores partnerships and licensing opportunities to share the benefits of its technologies with others, enabling the production and utilization of the enzymes they help create.
Dyadic International has raised $6.0M across 1 funding round on record, the most recent an undisclosed round of $6.0M announced in Mar 2024.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Dyadic International Company Profile and Key Stats
Latest funding round on record: Mar 2024.
Dyadic International Funding Rounds
Dyadic International Founders and Leadership Team
No contact details are on record for this team yet.
Dyadic International Funding Compared to Other Biotechnology Startups
Dyadic International's latest round of $6.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Dyadic International in Biotechnology and Jupiter
Companies Similar to Dyadic International
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Dyadic International Funding FAQs
What does Dyadic International do?
Dyadic International, Inc. is a global biotechnology company based in Jupiter, Florida, with a research facility in the Netherlands. Using its unique technologies, Dyadic conducts research and development in order to discover, develop, manufacture, and sell enzymes and other proteins for various industries. The company's integrated technology platform, based on its patented C1 fungus, allows for the cost-effective production of enzymes and proteins for different market uses. Dyadic also explores partnerships and licensing opportunities to share the benefits of its technologies with others, enabling the production and utilization of the enzymes they help create.
How much funding has Dyadic International raised?
Dyadic International has raised $6.0M across 1 round on record. The most recent is an undisclosed round of $6.0M announced in Mar 2024.
When did Dyadic International last raise funding?
Dyadic International's most recent funding round on record is an undisclosed round of $6.0M, announced in Mar 2024.
Who founded Dyadic International?
FundedIQ lists Mark A Emalfarb (Founder) at Dyadic International.
Where is Dyadic International headquartered?
Dyadic International is based in Jupiter, Florida, United States.
How many employees does Dyadic International have?
Dyadic International is in the 51-100 employee band.
How does Dyadic International's funding compare to other Biotechnology startups?
Dyadic International's latest round of $6.0M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Dyadic International Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Dyadic International is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.